First-pass extracted concept

cytochrome P-450-mediated biotransformation

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

The toxicities are not attributable to the compounds per se, but rather to metabolites produced by cytochrome P-450-mediated biotransformations.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review1995Anesthesia & AnalgesiaDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1comparative safety summarysupports1995Source 1DOI PubMed

Among inhaled anesthetics in current use at the time of the review, halothane is associated with rare but severe hepatotoxicity, whereas hepatitis after enflurane or isoflurane exposure is reported to be much rarer.

Claim 2evidence gap summaryneutral1995Source 1DOI PubMed

The review discusses the potential toxicity of sevoflurane in light of known mechanisms from other inhaled anesthetics rather than concluding established human organ toxicity.

Claim 3mechanism summarysupports1995Source 1DOI PubMed

Both hepatotoxicity and nephrotoxicity can arise from generation of cytotoxic metabolites within the target organ.

Claim 4mechanism summarysupports1995Source 1DOI PubMed

Organ toxicities of inhaled anesthetics are attributed primarily to metabolites generated by cytochrome P-450-mediated biotransformation rather than to the parent anesthetic compounds themselves.